Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective Tissue

Explore clinical trials studying Neoplasms, Connective Tissue. Study availability and eligibility vary by location and protocol.

1,282 public trials 272 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective Tissue trial results

Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

NCT03715933

Conditions
Colorectal Adenocarcinoma, Ewing Sarcoma, Neoplasms, +7 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Precision NextGen Oncology and Research Beverly Hills, California, United States
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 37 locations
View Trial Details
Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 29 locations
View Trial Details
Recruiting

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT06422806

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Liposarcoma, +13 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 257 locations
View Trial Details
Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions
Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Grand Valley Oncology Grand Junction, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 26 locations
View Trial Details
Recruiting

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

NCT04094610

Conditions
Astrocytoma, Glioblastoma, Glioma, +30 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado - Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 2105 Orlando, Florida, United States
View all 68 locations
View Trial Details
Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

NCT05711615

Conditions
Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +24 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details
Recruiting

An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)

NCT07264959

Conditions
Immune System Diseases, Indolent Systemic Mastocytosis, Mast Cell Activation Disorders, +6 more
Locations
  • Brigham and Women's Allergy and Clinical Immunology, Mass General Brigham Healthcare Center (Chestnut Hill) Chestnut Hill, Massachusetts, United States
  • Institute for Allergy and Asthma Wheaton, Maryland, United States
  • University of Michigan Allergy Clinic Ann Arbor, Michigan, United States
  • University of Colorado Aurora, Colorado, United States
View Trial Details
Recruiting

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

NCT06644755

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liposarcoma, +17 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • UZ Leuven Europe Leuven Leuven, Belgium
View Trial Details

Related conditions